EVT Innovate: Building bridges between cutting edge science and transformative pharma projects
Within the EVT Innovate segment, Evotec leverages its proprietary technology platforms to develop new drug discovery projects, assets and platforms, both internally or through collaborations to create starting points for strategic partnerships with Pharma and leading biotech companies in return for upfront payments, ongoing research payments, and significant financial upside through milestones and royalties. Evotec does not take clinical development risks on its own but only within alliances.
Additionally, Evotec builds translational (BRIDGE) partnerships with Academia and selectively participates in high-potential ventures through strategic investments and company formations through EVT Innovate.
